协同激活剂SRC1与FXR-RXRα的不对称结合以及复合体内的全oster通信的结构基础
Yanan Sheng1,2, Yaoting Guo2, Beibei Zhao1,2
1Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230026, China.
Communications biology
|March 14, 2025
概括
模拟了Farnesoid X受体 (FXR) 与协同激活剂SRC1的相互作用,揭示了SRC1如何在FXR-RXRα-DNA复合体内结合FXR. 这为FXR提供了洞察力.
科学领域:
- 分子生物学分子生物学
- 结构生物学是结构生物学.
- 生物化学 生物化学
背景情况:
- 与代谢相关的脂肪肝疾病 (MAFLD) 是一个日益严重的健康问题.
- 法尔内索伊德X受体 (FXR) 是MAFLD的一个关键治疗点.
- 了解FXR的分子相互作用对于药物开发至关重要.
研究的目的:
- 研究FXR-RXRα-DNA复合体与SRC1核受体相互作用域 (NRID) 之间的相互作用.
- 阐明联合激活剂与FXR结合的分子机制.
- 为FXR向治疗提供结构基础.
主要方法:
- 整合性结构生物学方法.
- 对FXR-RXRα-DNA复合物的多域建模.
- -交换质谱法 (HDX-MS). 交换质谱法 (HDX-MS). 交换质谱法 (HDX-MS). 交换质谱法 (HDX-MS). 交换质谱法 (HDX-MS). 交换质谱法 (HDX-MS). 交换质谱法 (HDX-MS). 交换质谱法.
- 交叉连接质谱学 (XL-MS).
- 生物化学测试. 生物化学测试.
主要成果:
- 构建了FXR-RXRα-DNA的多域模型,显示了FXR的DNA结合域 (DBD) 和连接体结合域 (LBD) 之间的接口.
- 在agonist和DNA结合时,在FXR-RXRα-DNA复合体内确定了Allosteric通信.
- 证实SRC1与异体聚合物中的FXR的同活性剂结合表面不对称地结合.
- SRC1的NR-box2和NR-box3被确定为关键的结合基因.
结论:
- 这项研究提出了SRC1-NRID与FXR-RXRα-DNA复合的第一个结构模型.
- 这些发现揭示了联合激活剂和核受体之间的不对称相互作用机制.
- 为了解FXR功能及其在疾病中的作用提供了一个结构基础.
相关概念视频
Cooperative Binding of Transcription Regulators
6.3K
Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome. Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...
6.3K
Co-activators and Co-repressors
7.2K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.2K
Cooperative Allosteric Transitions
7.8K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.8K
Assembly of Signaling Complexes
5.7K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
5.7K
Ligand Binding and Linkage
4.7K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.7K
Allosteric Regulation
57.4K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
57.4K


